|
|
|
Insider
Information: |
Wigginton Jon Marc |
Relationship: |
Sr VP, Clinical Dev. &... |
City: |
Rockville |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
18,930 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$84,617 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
18,930 |
|
|
Total
Value |
$84,617 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Macrogenics Inc |
MGNX |
Sr VP, Clinical Dev. &... |
2018-02-26 |
18,930 |
2014-08-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2017-04-19 |
4 |
AS |
$20.00 |
$300,000 |
D/D |
(15,000) |
30,000 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2017-06-05 |
4 |
AS |
$20.00 |
$100,000 |
D/D |
(5,000) |
30,000 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2017-06-05 |
4 |
OE |
$4.70 |
$23,500 |
D/D |
5,000 |
35,000 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2017-10-25 |
4 |
OE |
$4.70 |
$47,000 |
D/D |
10,000 |
40,000 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2017-10-25 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
30,000 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2017-11-21 |
4 |
OE |
$4.70 |
$23,500 |
D/D |
5,000 |
35,000 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2017-11-21 |
4 |
AS |
$20.00 |
$100,000 |
D/D |
(5,000) |
30,000 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2018-01-16 |
4 |
AS |
$20.00 |
$49,520 |
D/D |
(2,476) |
30,000 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2018-01-16 |
4 |
OE |
$4.70 |
$11,637 |
D/D |
2,476 |
32,476 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2018-01-17 |
4 |
OE |
$4.70 |
$11,863 |
D/D |
2,524 |
32,524 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2018-01-17 |
4 |
AS |
$20.00 |
$50,480 |
D/D |
(2,524) |
30,000 |
0 |
- |
|
MGNX |
Macrogenics Inc |
Sr VP, Clinical Dev. & CMO |
|
2018-02-26 |
4 |
D |
$23.46 |
$259,702 |
D/D |
(11,070) |
18,930 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|